retatrutide benefits clinical trials retatrutide UK | The Ultimate Guide | Latest Trial Retatrutide Phase 3: 60% Achieved

What Can I Expect At My Medical Weight Loss Appointment

Unveiling the cost-effectiveness of bariatric surgery: insights from a matched cohort study

[10] SURMOUNT-1 : Tirzepatide for the treatment of obesity produced ~2022% weight loss over 72 weeks, among the largest effects seen in pharmacologic obesity treatment

6 This benefit is irrespective of weight loss, blood pressure reduction or improvement in glycaemic index associated with these drugs

Note: Ozempic is not FDA-approved to treat obesity or for weight loss.

41 In a mouse model of colitis, using an antagonist for SDF-1 receptor resulted in a reduction in colonic inflammation manifested as a reduction in the production of pro-inflammatory cytokines and an improvement in colonic pathology